Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy.
Neutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV-1 infection in some individuals. Further knowledge is required in order to understand the factors contributing to induction of cross-reactive NAb responses. Here a well-established model of experimen...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
2010
|
| _version_ | 1797055636836450304 |
|---|---|
| author | Ozkaya Sahin, G Bowles, E Parker, J Uchtenhagen, H Sheik-Khalil, E Taylor, S Pybus, O Mäkitalo, B Walther-Jallow, L Spångberg, M Thorstensson, R Achour, A Fenyö, E Stewart-Jones, G Spetz, A |
| author_facet | Ozkaya Sahin, G Bowles, E Parker, J Uchtenhagen, H Sheik-Khalil, E Taylor, S Pybus, O Mäkitalo, B Walther-Jallow, L Spångberg, M Thorstensson, R Achour, A Fenyö, E Stewart-Jones, G Spetz, A |
| author_sort | Ozkaya Sahin, G |
| collection | OXFORD |
| description | Neutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV-1 infection in some individuals. Further knowledge is required in order to understand the factors contributing to induction of cross-reactive NAb responses. Here a well-established model of experimental pathogenic infection in cynomolgus macaques, which reproduces long-lasting HIV-1 infection, was used to study the NAb response as well as the viral evolution of the highly neutralization-resistant SIVmac239. Twelve animals were infected intravenously with SIVmac239. Antiretroviral therapy (ART) was initiated ten days post-inoculation and administered daily for four months. Viral load, CD4(+) T-cell counts, total IgG levels, and breadth as well as strength of NAb in plasma were compared simultaneously over 14 months. In addition, envs from plasma samples were sequenced at three time points in all animals in order to assess viral evolution. We report here that seven of the 12 animals controlled viremia to below 10(4) copies/ml of plasma after discontinuation of ART and that this control was associated with a low level of evolutionary divergence. Macaques that controlled viral load developed broader NAb responses early on. Furthermore, escape mutations, such as V67M and R751G, were identified in virus sequenced from all animals with uncontrolled viremia. Bayesian estimation of ancestral population genetic diversity (PGD) showed an increase in this value in non-controlling or transient-controlling animals during the first 5.5 months of infection, in contrast to virus-controlling animals. Similarly, non- or transient controllers displayed more positively-selected amino-acid substitutions. An early increase in PGD, resulting in the generation of positively-selected amino-acid substitutions, greater divergence and relative high viral load after ART withdrawal, may have contributed to the generation of potent NAb in several animals after SIVmac239 infection. However, early broad NAb responses correlated with relatively preserved CD4(+) T-cell numbers, low viral load and limited viral divergence. |
| first_indexed | 2024-03-06T19:12:36Z |
| format | Journal article |
| id | oxford-uuid:17423a82-1e86-4675-915a-071b527ef9cc |
| institution | University of Oxford |
| last_indexed | 2024-03-06T19:12:36Z |
| publishDate | 2010 |
| record_format | dspace |
| spelling | oxford-uuid:17423a82-1e86-4675-915a-071b527ef9cc2022-03-26T10:36:15ZGeneration of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:17423a82-1e86-4675-915a-071b527ef9ccSymplectic Elements at Oxford2010Ozkaya Sahin, GBowles, EParker, JUchtenhagen, HSheik-Khalil, ETaylor, SPybus, OMäkitalo, BWalther-Jallow, LSpångberg, MThorstensson, RAchour, AFenyö, EStewart-Jones, GSpetz, ANeutralizing antibodies (NAb) able to react to heterologous viruses are generated during natural HIV-1 infection in some individuals. Further knowledge is required in order to understand the factors contributing to induction of cross-reactive NAb responses. Here a well-established model of experimental pathogenic infection in cynomolgus macaques, which reproduces long-lasting HIV-1 infection, was used to study the NAb response as well as the viral evolution of the highly neutralization-resistant SIVmac239. Twelve animals were infected intravenously with SIVmac239. Antiretroviral therapy (ART) was initiated ten days post-inoculation and administered daily for four months. Viral load, CD4(+) T-cell counts, total IgG levels, and breadth as well as strength of NAb in plasma were compared simultaneously over 14 months. In addition, envs from plasma samples were sequenced at three time points in all animals in order to assess viral evolution. We report here that seven of the 12 animals controlled viremia to below 10(4) copies/ml of plasma after discontinuation of ART and that this control was associated with a low level of evolutionary divergence. Macaques that controlled viral load developed broader NAb responses early on. Furthermore, escape mutations, such as V67M and R751G, were identified in virus sequenced from all animals with uncontrolled viremia. Bayesian estimation of ancestral population genetic diversity (PGD) showed an increase in this value in non-controlling or transient-controlling animals during the first 5.5 months of infection, in contrast to virus-controlling animals. Similarly, non- or transient controllers displayed more positively-selected amino-acid substitutions. An early increase in PGD, resulting in the generation of positively-selected amino-acid substitutions, greater divergence and relative high viral load after ART withdrawal, may have contributed to the generation of potent NAb in several animals after SIVmac239 infection. However, early broad NAb responses correlated with relatively preserved CD4(+) T-cell numbers, low viral load and limited viral divergence. |
| spellingShingle | Ozkaya Sahin, G Bowles, E Parker, J Uchtenhagen, H Sheik-Khalil, E Taylor, S Pybus, O Mäkitalo, B Walther-Jallow, L Spångberg, M Thorstensson, R Achour, A Fenyö, E Stewart-Jones, G Spetz, A Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy. |
| title | Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy. |
| title_full | Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy. |
| title_fullStr | Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy. |
| title_full_unstemmed | Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy. |
| title_short | Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy. |
| title_sort | generation of neutralizing antibodies and divergence of sivmac239 in cynomolgus macaques following short term early antiretroviral therapy |
| work_keys_str_mv | AT ozkayasahing generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT bowlese generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT parkerj generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT uchtenhagenh generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT sheikkhalile generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT taylors generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT pybuso generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT makitalob generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT waltherjallowl generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT spangbergm generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT thorstenssonr generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT achoura generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT fenyoe generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT stewartjonesg generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy AT spetza generationofneutralizingantibodiesanddivergenceofsivmac239incynomolgusmacaquesfollowingshorttermearlyantiretroviraltherapy |